Micell Technologies

801 Capitola Dr
Suite 104
Durham
NC
27713-4384
USA
Phone: 
919-313-2102
http://www.micell.com
info@micell.com
Product Categories: Taxo=stents,_drug_eluting&Taxo=stents&Taxo=cath_lab&Taxo=diagnostic_and_interventional_cardiology_daic

Related Articles

Stents, Bioresorbable

Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

Clinical Trial/Study

Micell Technologies Announces Preliminary Data from DESSOLVE I MiStent DES Study
Enrollment Completed in DESSOLVE II Study of the MiStent Drug-Eluting Coronary Stent
Micell Reduces Trial Sample Size for MiStent
Consistent, Controlled Drug Delivery Reported With Rapidly Absorbable Stent Coating
First Patient Enrolled in Dissolving Drug-Polymer Coronary Stent Trial

Stents, Drug Eluting

Micell Technologies Announces Preliminary Data from DESSOLVE I MiStent DES Study
Enrollment Completed in DESSOLVE II Study of the MiStent Drug-Eluting Coronary Stent
Micell Reduces Trial Sample Size for MiStent
Consistent, Controlled Drug Delivery Reported With Rapidly Absorbable Stent Coating
First Patient Enrolled in Dissolving Drug-Polymer Coronary Stent Trial

Stents

Enrollment Completed in DESSOLVE II Study of the MiStent Drug-Eluting Coronary Stent
Micell Reduces Trial Sample Size for MiStent